Clinical Trial

A Clinical Study of SHR-A1811(sc) Subcutaneous Injection in Patients With Solid Tumor

Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
The study is being conducted to evaluate the pharmacokinetics , safety, tolerability and efficacy in patients with solid tumor.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-11-27.
Status change: Not Yet Recruiting → Recruiting 2026-01-13
Trial Details
NCT Number NCT07275242
Lead Sponsor Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Conditions Solid Tumor
Enrollment 107 participants
Start Date 2025-12-23
Primary Completion 2027-06 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2026-01-15